Alnylam Pharmaceuticals
ALNY
#569
Rank
$41.36 B
Marketcap
$311.92
Share price
-1.67%
Change (1 day)
28.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company